Literature DB >> 28500778

Phaeohyphomycosis due to Exophiala infections in solid organ transplant recipients: Case report and literature review.

Kate E Oberlin1, Anna J Nichols1, Rossana Rosa2, Adriana Dejman3, Adela Mattiazzi3, Giselle Guerra3, George W Elgart1, Lilian M Abbo2.   

Abstract

This case report and literature review underscores the cutaneous presentations of phaeohyphomycosis in the solid organ transplant population. Increased cognizance with prompt identification is critical. The therapy and clinical outcomes of phaeohyphomycosis, caused by the Exophiala genus, in the solid organ transplant population, is analyzed to examine optimal care. This review highlights the inherent difficulties in providing the appropriate duration of antifungal therapy to avoid relapsing infections in immunosuppressed patients.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Exophialazzm321990; chromoblastomycosis; immunosuppression; phaeohyphomycosis; transplant

Mesh:

Substances:

Year:  2017        PMID: 28500778     DOI: 10.1111/tid.12723

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  A case of Phaeohyphomycosis caused by Corynespora cassiicola infection.

Authors:  Zhaolu Xie; Wei Wu; Desheng Meng; Qing Zhang; Yunqi Ma; Wen Liu; Jianhong Chen
Journal:  BMC Infect Dis       Date:  2018-08-31       Impact factor: 3.090

2.  Phialemoniopsis limonesiae sp. nov. causing cutaneous phaeohyphomycosis in an immunosuppressed woman.

Authors:  D Alvarez Martinez; C Alberto; A Riat; C Schuhler; P Valladares; B Ninet; B Kraak; P W Crous; L W Hou; L Toutous Trellu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 3.  Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

Authors:  Emilie Corvilain; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2018-08-22       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.